Document is current

Any future updates will be listed below

Pembrolizumab plus Radiochemotherapie bei lokal fortgeschrittenem Zervixkarzinom – die prospektive, randomisierte KEYNOTE-A18-Phase-3-Studie

Crossref DOI link: https://doi.org/10.1007/s00066-024-02298-4

Published Online: 2024-09-04

Published Print: 2024-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark